PMID- 12368701 OWN - NLM STAT- MEDLINE DCOM- 20021107 LR - 20190916 IS - 1077-4114 (Print) IS - 1077-4114 (Linking) VI - 24 IP - 7 DP - 2002 Oct TI - Successful matched-unrelated bone marrow transplantation in a patient with beta-thalassemia major. PG - 579-81 AB - The authors describe a 5-year-old boy with beta-thalassemia major who received bone marrow transplantation (BMT) from a human leukocyte antigen (HLA)-matched unrelated donor. The conditioning regimen consisted of 16 mg/kg busulfan and 200 mg/kg cyclophosphamide. The transplantation was complicated with grade II graft-versus-host disease, although prophylaxis with cyclosporine and short-term methotrexate was carried out. Cytomegalovirus disease occurred at 2 months after transplantation but was controlled successfully. The child remains disease-free and in good clinical condition 53 months after BMT. The authors suggest that BMT from an HLA-matched unrelated donor could be considered as an alternative treatment in patients with beta-thalassemia major when no HLA-matched donor is available. FAU - Cheng, Chao-Neng AU - Cheng CN AD - Department of Pediatrics, National Cheng Kung University Hospital, Tainan, Taiwan. FAU - Lu, Cheng-Chan AU - Lu CC FAU - Sun, Hsiao-Fang Sunny AU - Sun HF FAU - Su, Wu-Chou AU - Su WC FAU - Chen, Jiann-Shiuh AU - Chen JS LA - eng PT - Case Reports PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - J Pediatr Hematol Oncol JT - Journal of pediatric hematology/oncology JID - 9505928 RN - 0 (HLA Antigens) SB - IM MH - Adult MH - Bone Marrow/immunology/metabolism MH - Bone Marrow Transplantation/*immunology MH - Child, Preschool MH - Female MH - Genotype MH - HLA Antigens/genetics/immunology MH - Humans MH - Male MH - Tissue Donors MH - beta-Thalassemia/*immunology/*therapy EDAT- 2002/10/09 04:00 MHDA- 2002/11/26 04:00 CRDT- 2002/10/09 04:00 PHST- 2002/10/09 04:00 [pubmed] PHST- 2002/11/26 04:00 [medline] PHST- 2002/10/09 04:00 [entrez] AID - 10.1097/00043426-200210000-00019 [doi] PST - ppublish SO - J Pediatr Hematol Oncol. 2002 Oct;24(7):579-81. doi: 10.1097/00043426-200210000-00019.